147 related articles for article (PubMed ID: 18082864)
1. Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line.
Laplante Y; Poirier D
Steroids; 2008 Mar; 73(3):266-71. PubMed ID: 18082864
[TBL] [Abstract][Full Text] [Related]
2. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623
[TBL] [Abstract][Full Text] [Related]
3. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
4. Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol.
Chen F; Knecht K; Leu C; Rutledge SJ; Scafonas A; Gambone C; Vogel R; Zhang H; Kasparcova V; Bai C; Harada S; Schmidt A; Reszka A; Freedman L
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):247-57. PubMed ID: 15336702
[TBL] [Abstract][Full Text] [Related]
5. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism.
Jin Y; Penning TM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):79-94. PubMed ID: 11469812
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid hormone metabolism and prostate cancer.
Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
[TBL] [Abstract][Full Text] [Related]
7. [The role of the hypophysis and the hypophyseal hormone prolactin in maintenance of the sexual specificity of the metabolism of testosterone and 5-alpha-dihydrotestosterone in rat liver slices].
Schriefers H; Keck E; Klein S; Schröder E
Hoppe Seylers Z Physiol Chem; 1975 Oct; 356(10):1535-43. PubMed ID: 1213671
[TBL] [Abstract][Full Text] [Related]
8. 7alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents.
Labaree DC; Hoyte RM; Nazareth LV; Weigel NL; Hochberg RB
J Med Chem; 1999 Jun; 42(11):2021-34. PubMed ID: 10354410
[TBL] [Abstract][Full Text] [Related]
9. Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.
Tchédam Ngatcha B; Luu-The V; Labrie F; Poirier D
J Med Chem; 2005 Aug; 48(16):5257-68. PubMed ID: 16078844
[TBL] [Abstract][Full Text] [Related]
10. Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro.
Kirilovas D; Naessen T; Bergström M; Bonasera TA; Bergström-Pettermann E; Holte J; Carlström K; Simberg N; Långström B
Acta Obstet Gynecol Scand; 2003 Mar; 82(3):209-15. PubMed ID: 12694114
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of androst-4-ene-3,17-dione by subcellular fractions of rat adrenal tissue with particular reference to microsomal C19-steroid 5alpha-reductase.
Maynard PV; Cameron EH
Biochem J; 1973 Feb; 132(2):283-91. PubMed ID: 4146836
[TBL] [Abstract][Full Text] [Related]
12. Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells.
Thériault C; Labrie F
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):155-64. PubMed ID: 2004038
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase.
Dufort I; Rheault P; Huang XF; Soucy P; Luu-The V
Endocrinology; 1999 Feb; 140(2):568-74. PubMed ID: 9927279
[TBL] [Abstract][Full Text] [Related]
14. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
15. 5alpha-dihydrotestosterone-binding proteins and androgen sensitivity in prostatic cancers of Copenhangen rats.
Voigt W; Feldman M; Dunning WF
Cancer Res; 1975 Jul; 35(7):1840-6. PubMed ID: 165887
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
17. In situ androgen producing enzymes in human prostate cancer.
Nakamura Y; Suzuki T; Nakabayashi M; Endoh M; Sakamoto K; Mikami Y; Moriya T; Ito A; Takahashi S; Yamada S; Arai Y; Sasano H
Endocr Relat Cancer; 2005 Mar; 12(1):101-7. PubMed ID: 15788642
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development.
Killian J; Pratis K; Clifton RJ; Stanton PG; Robertson DM; O'Donnell L
Biol Reprod; 2003 May; 68(5):1711-8. PubMed ID: 12606426
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3).
Spires TE; Fink BE; Kick EK; You D; Rizzo CA; Takenaka I; Lawrence RM; Ruan Z; Salvati ME; Vite GD; Weinmann R; Attar RM; Gottardis MM; Lorenzi MV
Prostate; 2005 Oct; 65(2):159-70. PubMed ID: 15924334
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.
Zimmerman RA; Dozmorov I; Nunlist EH; Tang Y; Li X; Cowan R; Centola M; Frank MB; Culkin DJ; Lin HK
Prostate Cancer Prostatic Dis; 2004; 7(4):364-74. PubMed ID: 15452555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
